PCFFS
BEAM icon

Pacific Center for Financial Services’s Beam Therapeutics BEAM Stock Holding History

Pacific Center for Financial Services’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-83
Closed -$3K – 397
2022
Q2 		$3K Hold
83
– – ﹤0.01% 340
2022
Q1 		$5K Hold
83
– – ﹤0.01% 313
2021
Q4 		$7K Hold
83
– – ﹤0.01% 299
2021
Q3 		$7K Buy
83
+12
+17% +$1.21K ﹤0.01% 307
2021
Q2 		$9K Hold
71
– – ﹤0.01% 266
2021
Q1 		$6K Hold
71
– – ﹤0.01% 273
2020
Q4 		$6K Buy
+71
New +$3.49K ﹤0.01% 264

Other funds holding BEAM

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacific Center for Financial Services's BEAM Position: Q3 2022 in Review

Pacific Center for Financial Services sold out of Beam Therapeutics (BEAM) in Q3 2022, closing a stake of 83 shares — an estimated $3K sold.

Pacific Center for Financial Services first reported a position in BEAM in Q4 2020 and held it in 7 quarters. The position peaked at $9K in Q2 2021. 224 funds tracked by Wall St. Rank hold BEAM as of Q3 2022.

  • Pacific Center for Financial Services reported no remaining Beam Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Pacific Center for Financial Services sold 83 Beam Therapeutics shares in Q3 2022, an estimated $3K.
  • Pacific Center for Financial Services first reported a position in Beam Therapeutics in Q4 2020 and held it in 7 quarters.
  • Pacific Center for Financial Services's Beam Therapeutics position peaked at $9K in Q2 2021.
  • 224 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2022.

Based on Pacific Center for Financial Services's 13F filing for Q3 2022, filed 14 Nov 2022.